25 XP   0   0   10

Jiangsu Aidea Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Aidea together

PenkeI guess you are interested in Jiangsu Aidea Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jiangsu Aidea Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jiangsu Aidea Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangsu Aidea Pharmaceutical Co Ltd.

Quick analysis of Aidea (30 sec.)










What can you expect buying and holding a share of Aidea? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥2.67
Expected worth in 1 year
¥2.50
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
¥-0.15
Return On Investment
-0.9%

For what price can you sell your share?

Current Price per Share
¥15.79
Expected price per share
¥13.30 - ¥17.40
How sure are you?
50%

1. Valuation of Aidea (5 min.)




Live pricePrice per Share (EOD)

¥15.79

Intrinsic Value Per Share

¥-8.15 - ¥-9.62

Total Value Per Share

¥-5.48 - ¥-6.94

2. Growth of Aidea (5 min.)




Is Aidea growing?

Current yearPrevious yearGrowGrow %
How rich?$155.3m$171.7m-$9.5m-5.9%

How much money is Aidea making?

Current yearPrevious yearGrowGrow %
Making money-$2.6m-$4.2m$1.6m63.3%
Net Profit Margin-20.9%-59.9%--

How much money comes from the company's main activities?

3. Financial Health of Aidea (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#294 / 1010

Most Revenue
#261 / 1010

Most Profit
#339 / 1010

Most Efficient
#488 / 1010

What can you expect buying and holding a share of Aidea? (5 min.)

Welcome investor! Aidea's management wants to use your money to grow the business. In return you get a share of Aidea.

What can you expect buying and holding a share of Aidea?

First you should know what it really means to hold a share of Aidea. And how you can make/lose money.

Speculation

The Price per Share of Aidea is ¥15.79. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aidea.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aidea, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.67. Based on the TTM, the Book Value Change Per Share is ¥-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aidea.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.01-0.1%-0.010.0%-0.010.0%0.000.0%0.000.0%
Usd Book Value Change Per Share-0.02-0.1%-0.010.0%-0.01-0.1%0.020.2%0.020.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-0.1%-0.010.0%-0.01-0.1%0.030.2%0.030.2%
Usd Price Per Share1.73-1.62-1.45-1.98-1.98-
Price to Earnings Ratio-30.18-516.99-522.03-430.79-430.79-
Price-to-Total Gains Ratio-106.26--190.47--511.18-428.73-428.73-
Price to Book Ratio4.68-4.22-3.55-4.70-4.70-
Price-to-Total Gains Ratio-106.26--190.47--511.18-428.73-428.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.17902
Number of shares458
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.02
Usd Total Gains Per Share-0.010.03
Gains per Quarter (458 shares)-2.3211.86
Gains per Year (458 shares)-9.2847.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12-11-1924537
24-22-2859084
35-33-377135131
47-44-469180178
59-55-5512225225
611-66-6414270272
712-77-7316316319
814-88-8219361366
916-99-9121406413
1018-110-10024451460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%4.08.00.033.3%7.08.00.046.7%7.08.00.046.7%7.08.00.046.7%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%5.010.00.033.3%5.010.00.033.3%5.010.00.033.3%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%15.00.00.0100.0%15.00.00.0100.0%15.00.00.0100.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%6.09.00.040.0%6.09.00.040.0%6.09.00.040.0%

Fundamentals of Aidea

About Jiangsu Aidea Pharmaceutical Co Ltd

Jiangsu Aidea Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and HIV diagnostic equipment and reagents. The company was founded in 2009 and is headquartered in Yangzhou, China.

Fundamental data was last updated by Penke on 2024-04-18 18:24:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Jiangsu Aidea Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Aidea earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Aidea to the Biotechnology industry mean.
  • A Net Profit Margin of -39.7% means that ¥-0.40 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jiangsu Aidea Pharmaceutical Co Ltd:

  • The MRQ is -39.7%. The company is making a huge loss. -2
  • The TTM is -20.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-39.7%TTM-20.9%-18.8%
TTM-20.9%YOY-59.9%+39.0%
TTM-20.9%5Y-23.6%+2.7%
5Y-23.6%10Y-23.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.7%-200.1%+160.4%
TTM-20.9%-216.8%+195.9%
YOY-59.9%-288.3%+228.4%
5Y-23.6%-449.1%+425.5%
10Y-23.6%-605.5%+581.9%
1.1.2. Return on Assets

Shows how efficient Aidea is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aidea to the Biotechnology industry mean.
  • -2.5% Return on Assets means that Aidea generated ¥-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jiangsu Aidea Pharmaceutical Co Ltd:

  • The MRQ is -2.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.5%TTM-1.1%-1.4%
TTM-1.1%YOY-1.9%+0.9%
TTM-1.1%5Y-0.7%-0.4%
5Y-0.7%10Y-0.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.5%-13.3%+10.8%
TTM-1.1%-12.8%+11.7%
YOY-1.9%-11.7%+9.8%
5Y-0.7%-13.9%+13.2%
10Y-0.7%-15.7%+15.0%
1.1.3. Return on Equity

Shows how efficient Aidea is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aidea to the Biotechnology industry mean.
  • -3.9% Return on Equity means Aidea generated ¥-0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jiangsu Aidea Pharmaceutical Co Ltd:

  • The MRQ is -3.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.9%TTM-1.7%-2.2%
TTM-1.7%YOY-2.5%+0.9%
TTM-1.7%5Y-0.9%-0.7%
5Y-0.9%10Y-0.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.9%-16.9%+13.0%
TTM-1.7%-16.1%+14.4%
YOY-2.5%-15.1%+12.6%
5Y-0.9%-19.3%+18.4%
10Y-0.9%-20.2%+19.3%

1.2. Operating Efficiency of Jiangsu Aidea Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Aidea is operating .

  • Measures how much profit Aidea makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aidea to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jiangsu Aidea Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-6.4%+6.4%
TTM-6.4%YOY-63.3%+56.9%
TTM-6.4%5Y-24.5%+18.1%
5Y-24.5%10Y-24.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM-6.4%-232.5%+226.1%
YOY-63.3%-298.2%+234.9%
5Y-24.5%-492.1%+467.6%
10Y-24.5%-632.4%+607.9%
1.2.2. Operating Ratio

Measures how efficient Aidea is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.81 means that the operating costs are ¥1.81 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jiangsu Aidea Pharmaceutical Co Ltd:

  • The MRQ is 1.807. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.741. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.807TTM1.741+0.066
TTM1.741YOY2.235-0.494
TTM1.7415Y1.837-0.096
5Y1.83710Y1.8370.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8073.231-1.424
TTM1.7413.310-1.569
YOY2.2353.890-1.655
5Y1.8375.739-3.902
10Y1.8377.876-6.039

1.3. Liquidity of Jiangsu Aidea Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Aidea is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.77 means the company has ¥1.77 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jiangsu Aidea Pharmaceutical Co Ltd:

  • The MRQ is 1.775. The company is able to pay all its short-term debts. +1
  • The TTM is 1.962. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.775TTM1.962-0.187
TTM1.962YOY4.251-2.290
TTM1.9625Y7.351-5.390
5Y7.35110Y7.3510.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7753.890-2.115
TTM1.9624.173-2.211
YOY4.2515.344-1.093
5Y7.3516.126+1.225
10Y7.3516.448+0.903
1.3.2. Quick Ratio

Measures if Aidea is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aidea to the Biotechnology industry mean.
  • A Quick Ratio of 0.81 means the company can pay off ¥0.81 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jiangsu Aidea Pharmaceutical Co Ltd:

  • The MRQ is 0.810. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.897. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.810TTM0.897-0.087
TTM0.897YOY1.874-0.978
TTM0.8975Y3.675-2.778
5Y3.67510Y3.6750.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8103.514-2.704
TTM0.8973.998-3.101
YOY1.8745.380-3.506
5Y3.6756.105-2.430
10Y3.6756.404-2.729

1.4. Solvency of Jiangsu Aidea Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Aidea assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aidea to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.36 means that Aidea assets are financed with 35.6% credit (debt) and the remaining percentage (100% - 35.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jiangsu Aidea Pharmaceutical Co Ltd:

  • The MRQ is 0.356. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.332. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.356TTM0.332+0.024
TTM0.332YOY0.216+0.115
TTM0.3325Y0.183+0.149
5Y0.18310Y0.1830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3560.339+0.017
TTM0.3320.336-0.004
YOY0.2160.271-0.055
5Y0.1830.366-0.183
10Y0.1830.389-0.206
1.4.2. Debt to Equity Ratio

Measures if Aidea is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aidea to the Biotechnology industry mean.
  • A Debt to Equity ratio of 55.2% means that company has ¥0.55 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jiangsu Aidea Pharmaceutical Co Ltd:

  • The MRQ is 0.552. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.499. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.552TTM0.499+0.053
TTM0.499YOY0.281+0.218
TTM0.4995Y0.249+0.249
5Y0.24910Y0.2490.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5520.388+0.164
TTM0.4990.402+0.097
YOY0.2810.335-0.054
5Y0.2490.426-0.177
10Y0.2490.461-0.212

2. Market Valuation of Jiangsu Aidea Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Aidea generates.

  • Above 15 is considered overpriced but always compare Aidea to the Biotechnology industry mean.
  • A PE ratio of -30.18 means the investor is paying ¥-30.18 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jiangsu Aidea Pharmaceutical Co Ltd:

  • The EOD is -38.087. Based on the earnings, the company is expensive. -2
  • The MRQ is -30.176. Based on the earnings, the company is expensive. -2
  • The TTM is 516.986. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-38.087MRQ-30.176-7.912
MRQ-30.176TTM516.986-547.162
TTM516.986YOY522.034-5.047
TTM516.9865Y430.791+86.195
5Y430.79110Y430.7910.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-38.087-2.264-35.823
MRQ-30.176-2.629-27.547
TTM516.986-2.680+519.666
YOY522.034-4.145+526.179
5Y430.791-6.257+437.048
10Y430.791-6.254+437.045
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jiangsu Aidea Pharmaceutical Co Ltd:

  • The EOD is -22.127. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -17.531. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 102.888. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-22.127MRQ-17.531-4.596
MRQ-17.531TTM102.888-120.419
TTM102.888YOY-20.566+123.454
TTM102.8885Y33.709+69.179
5Y33.70910Y33.7090.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-22.127-2.973-19.154
MRQ-17.531-3.333-14.198
TTM102.888-3.553+106.441
YOY-20.566-5.605-14.961
5Y33.709-8.376+42.085
10Y33.709-8.865+42.574
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Aidea is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.68 means the investor is paying ¥4.68 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Jiangsu Aidea Pharmaceutical Co Ltd:

  • The EOD is 5.903. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.677. Based on the equity, the company is fair priced.
  • The TTM is 4.223. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.903MRQ4.677+1.226
MRQ4.677TTM4.223+0.454
TTM4.223YOY3.548+0.675
TTM4.2235Y4.701-0.478
5Y4.70110Y4.7010.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.9031.896+4.007
MRQ4.6772.115+2.562
TTM4.2232.093+2.130
YOY3.5482.884+0.664
5Y4.7013.542+1.159
10Y4.7013.916+0.785
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jiangsu Aidea Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.127-0.044-66%-0.066-48%0.178-171%0.178-171%
Book Value Per Share--2.6752.793-4%2.958-10%2.907-8%2.907-8%
Current Ratio--1.7751.962-10%4.251-58%7.351-76%7.351-76%
Debt To Asset Ratio--0.3560.332+7%0.216+64%0.183+94%0.183+94%
Debt To Equity Ratio--0.5520.499+11%0.281+96%0.249+121%0.249+121%
Dividend Per Share--0.0090.007+28%0.002+271%0.009-5%0.009-5%
Eps---0.104-0.045-56%-0.045-56%-0.023-78%-0.023-78%
Free Cash Flow Per Share---0.178-0.141-21%-0.138-22%-0.090-49%-0.090-49%
Free Cash Flow To Equity Per Share---0.178-0.130-27%-0.022-88%0.038-569%0.038-569%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---9.619--------
Intrinsic Value_10Y_min---8.150--------
Intrinsic Value_1Y_max---0.531--------
Intrinsic Value_1Y_min---0.522--------
Intrinsic Value_3Y_max---1.926--------
Intrinsic Value_3Y_min---1.833--------
Intrinsic Value_5Y_max---3.719--------
Intrinsic Value_5Y_min---3.423--------
Market Cap6644163696.320+21%5263995430.0804954719919.200+6%4419273541.520+19%6047212868.971-13%6047212868.971-13%
Net Profit Margin---0.397-0.209-47%-0.599+51%-0.236-41%-0.236-41%
Operating Margin----0.0640%-0.6330%-0.2450%-0.2450%
Operating Ratio--1.8071.741+4%2.235-19%1.837-2%1.837-2%
Pb Ratio5.903+21%4.6774.223+11%3.548+32%4.701-1%4.701-1%
Pe Ratio-38.087-26%-30.176516.986-106%522.034-106%430.791-107%430.791-107%
Price Per Share15.790+21%12.51011.775+6%10.503+19%14.371-13%14.371-13%
Price To Free Cash Flow Ratio-22.127-26%-17.531102.888-117%-20.566+17%33.709-152%33.709-152%
Price To Total Gains Ratio-134.119-26%-106.259-190.473+79%-511.181+381%428.726-125%428.726-125%
Quick Ratio--0.8100.897-10%1.874-57%3.675-78%3.675-78%
Return On Assets---0.025-0.011-57%-0.019-22%-0.007-73%-0.007-73%
Return On Equity---0.039-0.017-57%-0.025-35%-0.009-76%-0.009-76%
Total Gains Per Share---0.118-0.037-69%-0.063-46%0.188-163%0.188-163%
Usd Book Value--155324273.382162211514.555-4%171774872.947-10%168812652.297-8%168812652.297-8%
Usd Book Value Change Per Share---0.017-0.006-66%-0.009-48%0.025-171%0.025-171%
Usd Book Value Per Share--0.3690.385-4%0.408-10%0.401-8%0.401-8%
Usd Dividend Per Share--0.0010.001+28%0.000+271%0.001-5%0.001-5%
Usd Eps---0.014-0.006-56%-0.006-56%-0.003-78%-0.003-78%
Usd Free Cash Flow---10359305.001-8191197.730-21%-8033396.407-22%-5249477.888-49%-5249477.888-49%
Usd Free Cash Flow Per Share---0.025-0.019-21%-0.019-22%-0.012-49%-0.012-49%
Usd Free Cash Flow To Equity Per Share---0.025-0.018-27%-0.003-88%0.005-569%0.005-569%
Usd Market Cap916894590.092+21%726431369.351683751348.850+6%609859748.730+19%834515375.918-13%834515375.918-13%
Usd Price Per Share2.179+21%1.7261.625+6%1.449+19%1.983-13%1.983-13%
Usd Profit---6018361.042-2624399.069-56%-4284994.314-29%-1779593.728-70%-1779593.728-70%
Usd Revenue--15153311.59514192052.690+7%8425564.809+80%10632337.613+43%10632337.613+43%
Usd Total Gains Per Share---0.016-0.005-69%-0.009-46%0.026-163%0.026-163%
 EOD+5 -3MRQTTM+9 -25YOY+10 -245Y+6 -2810Y+6 -28

3.2. Fundamental Score

Let's check the fundamental score of Jiangsu Aidea Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-38.087
Price to Book Ratio (EOD)Between0-15.903
Net Profit Margin (MRQ)Greater than0-0.397
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.810
Current Ratio (MRQ)Greater than11.775
Debt to Asset Ratio (MRQ)Less than10.356
Debt to Equity Ratio (MRQ)Less than10.552
Return on Equity (MRQ)Greater than0.15-0.039
Return on Assets (MRQ)Greater than0.05-0.025
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Jiangsu Aidea Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.000
Ma 20Greater thanMa 5015.693
Ma 50Greater thanMa 10014.658
Ma 100Greater thanMa 20013.551
OpenGreater thanClose15.420
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,746,565
Total Liabilities621,027
Total Stockholder Equity1,125,538
 As reported
Total Liabilities 621,027
Total Stockholder Equity+ 1,125,538
Total Assets = 1,746,565

Assets

Total Assets1,746,565
Total Current Assets872,381
Long-term Assets874,184
Total Current Assets
Cash And Cash Equivalents 225,356
Short-term Investments 215,749
Net Receivables 182,416
Inventory 184,878
Other Current Assets 5,815
Total Current Assets  (as reported)872,381
Total Current Assets  (calculated)814,214
+/- 58,167
Long-term Assets
Property Plant Equipment 443,539
Goodwill 13,239
Intangible Assets 191,207
Long-term Assets Other 13,738
Long-term Assets  (as reported)874,184
Long-term Assets  (calculated)661,723
+/- 212,462

Liabilities & Shareholders' Equity

Total Current Liabilities491,568
Long-term Liabilities129,459
Total Stockholder Equity1,125,538
Total Current Liabilities
Short Long Term Debt 339,405
Accounts payable 113,566
Other Current Liabilities 5,301
Total Current Liabilities  (as reported)491,568
Total Current Liabilities  (calculated)458,272
+/- 33,296
Long-term Liabilities
Long term Debt 69,940
Capital Lease Obligations Min Short Term Debt2,955
Long-term Liabilities  (as reported)129,459
Long-term Liabilities  (calculated)72,895
+/- 56,564
Total Stockholder Equity
Total Stockholder Equity (as reported)1,125,538
Total Stockholder Equity (calculated)0
+/- 1,125,538
Other
Capital Stock420,783
Common Stock Shares Outstanding 420,783
Net Debt 183,989
Net Invested Capital 1,534,883
Net Working Capital 380,813
Property Plant and Equipment Gross 443,539



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-30
> Total Assets 
707,973
1,404,320
1,446,827
1,462,604
1,451,886
1,428,921
1,434,614
1,500,559
1,596,053
1,616,824
1,655,202
1,697,709
1,798,735
1,799,030
1,746,565
1,746,5651,799,0301,798,7351,697,7091,655,2021,616,8241,596,0531,500,5591,434,6141,428,9211,451,8861,462,6041,446,8271,404,320707,973
   > Total Current Assets 
296,162
983,775
1,006,724
946,717
905,642
877,367
826,931
865,370
896,147
788,003
802,456
827,818
930,616
932,087
872,381
872,381932,087930,616827,818802,456788,003896,147865,370826,931877,367905,642946,7171,006,724983,775296,162
       Cash And Cash Equivalents 
90,851
345,505
244,684
245,923
388,773
380,571
442,706
270,322
487,565
240,143
134,908
204,347
302,351
336,607
225,356
225,356336,607302,351204,347134,908240,143487,565270,322442,706380,571388,773245,923244,684345,50590,851
       Short-term Investments 
0
450,000
536,314
473,567
237,956
250,452
163,312
353,447
155,353
266,840
351,637
230,633
185,771
180,439
215,749
215,749180,439185,771230,633351,637266,840155,353353,447163,312250,452237,956473,567536,314450,0000
       Net Receivables 
121,558
94,572
127,018
125,887
148,265
111,495
89,678
69,600
60,089
92,277
113,829
210,584
243,569
159,243
182,416
182,416159,243243,569210,584113,82992,27760,08969,60089,678111,495148,265125,887127,01894,572121,558
       Inventory 
71,451
78,727
88,061
91,251
113,943
120,648
114,269
148,371
158,162
172,437
156,151
162,331
172,385
192,042
184,878
184,878192,042172,385162,331156,151172,437158,162148,371114,269120,648113,94391,25188,06178,72771,451
       Other Current Assets 
12,302
14,971
10,647
10,090
16,706
14,200
16,965
23,630
34,978
16,306
6,640
19,923
26,540
3,853
5,815
5,8153,85326,54019,9236,64016,30634,97823,63016,96514,20016,70610,09010,64714,97112,302
   > Long-term Assets 
411,812
420,546
440,103
515,887
546,244
551,554
607,684
635,189
699,906
828,821
852,746
869,891
868,119
866,944
874,184
874,184866,944868,119869,891852,746828,821699,906635,189607,684551,554546,244515,887440,103420,546411,812
       Property Plant Equipment 
246,422
248,170
255,953
266,115
280,138
281,695
327,303
348,512
408,914
418,912
447,185
458,719
446,672
442,611
443,539
443,539442,611446,672458,719447,185418,912408,914348,512327,303281,695280,138266,115255,953248,170246,422
       Goodwill 
13,239
13,239
13,239
13,239
13,239
13,239
13,239
13,239
13,239
13,239
13,239
13,239
13,239
13,239
13,239
13,23913,23913,23913,23913,23913,23913,23913,23913,23913,23913,23913,23913,23913,23913,239
       Intangible Assets 
135,681
141,409
146,206
155,243
164,403
163,708
165,136
168,712
174,101
182,301
181,068
183,586
187,233
188,100
191,207
191,207188,100187,233183,586181,068182,301174,101168,712165,136163,708164,403155,243146,206141,409135,681
       Long-term Assets Other 
488
371
7,844
8,474
10,581
13,151
18,454
17,419
19,168
15,266
18,093
19,329
19,511
15,807
13,738
13,73815,80719,51119,32918,09315,26619,16817,41918,45413,15110,5818,4747,844371488
> Total Liabilities 
127,430
54,713
86,970
91,672
100,010
83,096
124,817
212,404
348,185
372,836
456,230
495,282
603,733
620,215
621,027
621,027620,215603,733495,282456,230372,836348,185212,404124,81783,096100,01091,67286,97054,713127,430
   > Total Current Liabilities 
113,281
40,594
73,003
74,780
85,814
69,477
92,542
113,143
239,482
246,673
331,675
370,338
481,092
490,049
491,568
491,568490,049481,092370,338331,675246,673239,482113,14392,54269,47785,81474,78073,00340,594113,281
       Short Long Term Debt 
60,065
0
0
0
1,479
1,119
4,230
4,497
87,791
102,387
147,271
168,586
308,293
328,329
339,405
339,405328,329308,293168,586147,271102,38787,7914,4974,2301,1191,47900060,065
       Accounts payable 
24,032
21,699
29,931
48,632
49,239
53,168
28,098
60,779
40,715
87,823
119,441
141,976
40,543
104,440
113,566
113,566104,44040,543141,976119,44187,82340,71560,77928,09853,16849,23948,63229,93121,69924,032
       Other Current Liabilities 
22,961
12,838
22,336
20,388
19,084
11,474
40,103
41,744
97,858
49,443
5,457
46,087
102,889
3,570
5,301
5,3013,570102,88946,0875,45749,44397,85841,74440,10311,47419,08420,38822,33612,83822,961
   > Long-term Liabilities 
14,149
14,119
13,967
16,892
14,197
13,619
32,275
99,262
108,703
126,164
124,555
124,944
122,641
130,166
129,459
129,459130,166122,641124,944124,555126,164108,70399,26232,27513,61914,19716,89213,96714,11914,149
       Capital Lease Obligations Min Short Term Debt
0
0
0
3,215
763
479
1,363
2,588
2,448
2,020
1,496
2,228
1,777
1,390
2,955
2,9551,3901,7772,2281,4962,0202,4482,5881,3634797633,215000
       Other Liabilities 
14,149
14,119
13,967
13,677
13,433
13,140
30,912
46,674
46,254
64,143
63,059
62,715
0
0
0
00062,71563,05964,14346,25446,67430,91213,14013,43313,67713,96714,11914,149
> Total Stockholder Equity
580,543
1,349,607
1,359,857
1,370,932
1,351,876
1,345,824
1,309,797
1,288,155
1,247,868
1,243,987
1,198,971
1,202,427
1,195,002
1,178,816
1,125,538
1,125,5381,178,8161,195,0021,202,4271,198,9711,243,9871,247,8681,288,1551,309,7971,345,8241,351,8761,370,9321,359,8571,349,607580,543
   Common Stock
360,000
420,000
420,000
420,000
420,000
420,000
420,000
420,000
420,000
420,000
420,000
420,000
0
0
0
000420,000420,000420,000420,000420,000420,000420,000420,000420,000420,000420,000360,000
   Retained Earnings 
50,985
56,083
66,264
77,593
58,965
52,745
16,118
-6,184
-52,073
-60,873
-108,084
-107,587
-126,981
-149,839
-193,450
-193,450-149,839-126,981-107,587-108,084-60,873-52,073-6,18416,11852,74558,96577,59366,26456,08350,985
   Accumulated Other Comprehensive Income 000000000000000
   Capital Surplus 000000000000000
   Treasury Stock000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue411,364
Cost of Revenue-221,336
Gross Profit190,028190,028
 
Operating Income (+$)
Gross Profit190,028
Operating Expense-479,711
Operating Income-68,347-289,683
 
Operating Expense (+$)
Research Development63,182
Selling General Administrative129,656
Selling And Marketing Expenses0
Operating Expense479,711192,838
 
Net Interest Income (+$)
Interest Income1,489
Interest Expense-11,764
Other Finance Cost-183
Net Interest Income-10,458
 
Pretax Income (+$)
Operating Income-68,347
Net Interest Income-10,458
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-92,085-68,347
EBIT - interestExpense = -11,764
-76,070
-64,306
Interest Expense11,764
Earnings Before Interest and Taxes (EBIT)0-80,321
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-92,085
Tax Provision--16,015
Net Income From Continuing Ops-76,070-76,070
Net Income-76,070
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net010,458
 

Technical Analysis of Aidea
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aidea. The general trend of Aidea is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aidea's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jiangsu Aidea Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 16.88 < 16.88 < 17.40.

The bearish price targets are: 13.66 > 13.65 > 13.30.

Tweet this
Jiangsu Aidea Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jiangsu Aidea Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jiangsu Aidea Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jiangsu Aidea Pharmaceutical Co Ltd. The current macd is 0.07577766.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aidea price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Aidea. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Aidea price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Jiangsu Aidea Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJiangsu Aidea Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jiangsu Aidea Pharmaceutical Co Ltd. The current adx is 22.48.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Aidea shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Jiangsu Aidea Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jiangsu Aidea Pharmaceutical Co Ltd. The current sar is 13.72.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Jiangsu Aidea Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jiangsu Aidea Pharmaceutical Co Ltd. The current rsi is 55.00. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Jiangsu Aidea Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartJiangsu Aidea Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jiangsu Aidea Pharmaceutical Co Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Aidea price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Jiangsu Aidea Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartJiangsu Aidea Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jiangsu Aidea Pharmaceutical Co Ltd. The current cci is -0.57535895.

Jiangsu Aidea Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartJiangsu Aidea Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jiangsu Aidea Pharmaceutical Co Ltd. The current cmo is 12.36.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Jiangsu Aidea Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJiangsu Aidea Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jiangsu Aidea Pharmaceutical Co Ltd. The current willr is -33.65384615.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Aidea is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jiangsu Aidea Pharmaceutical Co Ltd Daily Williams %R ChartJiangsu Aidea Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jiangsu Aidea Pharmaceutical Co Ltd.

Jiangsu Aidea Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jiangsu Aidea Pharmaceutical Co Ltd. The current atr is 0.86952769.

Jiangsu Aidea Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartJiangsu Aidea Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jiangsu Aidea Pharmaceutical Co Ltd. The current obv is 107,265,198.

Jiangsu Aidea Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartJiangsu Aidea Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jiangsu Aidea Pharmaceutical Co Ltd. The current mfi is 38.00.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Jiangsu Aidea Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartJiangsu Aidea Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jiangsu Aidea Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Jiangsu Aidea Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jiangsu Aidea Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.000
Ma 20Greater thanMa 5015.693
Ma 50Greater thanMa 10014.658
Ma 100Greater thanMa 20013.551
OpenGreater thanClose15.420
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Aidea with someone you think should read this too:
  • Are you bullish or bearish on Aidea? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aidea? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jiangsu Aidea Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangsu Aidea Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jiangsu Aidea Pharmaceutical Co Ltd.

Receive notifications about Jiangsu Aidea Pharmaceutical Co Ltd in your mailbox!